Higher Arm Versus Lower Arm Systolic Blood Pressure and Cardiovascular Outcomes: a Meta-Analysis of Individual Participant Data From the INTERPRESS-IPD Collaboration
Abstract:Background:
Guidelines recommend measuring blood pressure (BP) in both arms, adopting the higher arm readings for diagnosis and management. Data to support this recommendation are lacking. We evaluated associations of higher and lower arm systolic BPs with diagnostic and treatment thresholds, and prognosis in hypertension, using data from the Inter-arm Blood Pressure Difference—Individual Participant Data Collaboration.
Methods:
One-stage multivariable … Show more
“…Recent evidence showed that concordance of the higher BP arm‐side was 63% overall, rising to 73% and 92% when the mean IAD was equal to or higher than 5 and 10 mmHg, respectively. This confirms consistency of IADs, especially where the average IAD was equal to or higher than 10 mmHg 28 . In addition, Clark and associates found in their meta‐analysis that an IAD of 10 mmHg or more was associated with peripheral vascular disease.…”
Section: Discussionsupporting
confidence: 63%
“…This confirms consistency of IADs, especially where the average IAD was equal to or higher than 10 mmHg. 28 In addition, Clark and associates found in their meta-analysis that an IAD of 10 mmHg or more was associated with peripheral vascular disease. This finding was based on 20 studies of which the majority did not use the consistency method.…”
Section: Strengths and Limitations Of The Approachmentioning
confidence: 99%
“…We recently found a positive hazard for smoking in our individual participant data modeling of all-cause mortality taking account of IAD, although total cholesterol appeared to have a negative relationship. 6,43 The presence of AF is associated with peripheral artery disease. 44 A systolic IAD ≥ 15 mmHg has previously been labelled subclavian stenosis, and it indicates a 2.5 times risk of presence of peripheral artery disease in comparison with lower IADs.…”
Section: Implications For Clinical Practicementioning
confidence: 99%
“…[1][2][3][4] Inter-arm differences (IAD) in BP have been associated with peripheral arterial disease and increased cardiovascular and all-cause mortality. 5,6 Despite these recommendations, bilateral BP measurements are often not performed in routine clinical practice. [7][8][9] This may be due to uncertainties around appropriate methods of bilateral BP measurement and correct interpretation and management of an IAD.…”
Section: Introductionmentioning
confidence: 99%
“…[14][15][16][17] However, recent evidence has confirmed the prognostic value of sequentially measured arm BPs. 6 The purpose of this study was to 1) determine the prevalence of absolute IADs in BP in a large representative primary care cohort in India, 2) compare prevalence's of IAD with clinically significant IAD cutoff values recommended in international BP guidelines and existing literature, and 3) determine the relationship between IADs and patient characteristics.…”
The version presented here may differ from the published version. If citing, you are advised to consult the published version for pagination, volume/issue and date of publication
“…Recent evidence showed that concordance of the higher BP arm‐side was 63% overall, rising to 73% and 92% when the mean IAD was equal to or higher than 5 and 10 mmHg, respectively. This confirms consistency of IADs, especially where the average IAD was equal to or higher than 10 mmHg 28 . In addition, Clark and associates found in their meta‐analysis that an IAD of 10 mmHg or more was associated with peripheral vascular disease.…”
Section: Discussionsupporting
confidence: 63%
“…This confirms consistency of IADs, especially where the average IAD was equal to or higher than 10 mmHg. 28 In addition, Clark and associates found in their meta-analysis that an IAD of 10 mmHg or more was associated with peripheral vascular disease. This finding was based on 20 studies of which the majority did not use the consistency method.…”
Section: Strengths and Limitations Of The Approachmentioning
confidence: 99%
“…We recently found a positive hazard for smoking in our individual participant data modeling of all-cause mortality taking account of IAD, although total cholesterol appeared to have a negative relationship. 6,43 The presence of AF is associated with peripheral artery disease. 44 A systolic IAD ≥ 15 mmHg has previously been labelled subclavian stenosis, and it indicates a 2.5 times risk of presence of peripheral artery disease in comparison with lower IADs.…”
Section: Implications For Clinical Practicementioning
confidence: 99%
“…[1][2][3][4] Inter-arm differences (IAD) in BP have been associated with peripheral arterial disease and increased cardiovascular and all-cause mortality. 5,6 Despite these recommendations, bilateral BP measurements are often not performed in routine clinical practice. [7][8][9] This may be due to uncertainties around appropriate methods of bilateral BP measurement and correct interpretation and management of an IAD.…”
Section: Introductionmentioning
confidence: 99%
“…[14][15][16][17] However, recent evidence has confirmed the prognostic value of sequentially measured arm BPs. 6 The purpose of this study was to 1) determine the prevalence of absolute IADs in BP in a large representative primary care cohort in India, 2) compare prevalence's of IAD with clinically significant IAD cutoff values recommended in international BP guidelines and existing literature, and 3) determine the relationship between IADs and patient characteristics.…”
The version presented here may differ from the published version. If citing, you are advised to consult the published version for pagination, volume/issue and date of publication
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.